Gümligen, Bern, Switzerland BVGroup appeared to be the Corporate Investor, which was created in 1997. The venture was found in Europe in Switzerland. The main department of described Corporate Investor is located in the Gu00fcmligen.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the BVGroup, startups are often financed by VI Partners AG, Novartis Venture Fund, Erfindungs Verwertung. The meaningful sponsors for the fund in investment in the same round are Venture Incubator, LLC, Novartis.
We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Covalys Biosciences, Anecova, Finox Biotech For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland.
The fund is constantly included in less than 2 deals per year. The real fund results show that this Corporate Investor is 13 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this BVGroup works on 4 percentage points more the average amount of lead investments. The top amount of exits for fund were in 2016. The high activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.
Related Funds
| Fund Name | Location |
| A&B (HK) | - |
| Adelie | France, Ile-de-France, Paris |
| BERRIUP | Autonomous Community of the Basque Country, San Sebastián, Spain |
| Boyue Changxing Industrial | China, Hubei, Wuhan Shi |
| Clare Island Media GmbH | - |
| CR-CP Life Science Fund | China, Hong Kong, Hong Kong Island |
| Crocker Mountain Capital | - |
| DCVC Opportunity | - |
| Ehime Bank | Ehime Prefecture, Japan, Matsuyama |
| Inspovation Ventures | California, Los Altos, United States |
| Jinsheng Capital | - |
| MedImmune | Louisiana, Maryland, United States |
| Playground Global | California, Palo Alto, United States |
| Powe Capital Management | England, London, United Kingdom |
| SK Holdings | Seoul, Seoul-t'ukpyolsi, South Korea |
| Srijan Capital | Bangalore, India, Karnataka |
| SSE | Australia, Perth, Western Australia |
| Starstrike Ventures | Berlin, Berlin, Germany |
| Zhejiang Zhuji Intelligent Security Industry Fund | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Covalys Biosciences | 06 Mar 2006 | Bern, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Covalys Biosciences | 06 Mar 2006 | Bern, Switzerland |
